Pregnancy News and Research

Latest Pregnancy News and Research

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

23 Oct 2009

Combination treatement for IVF patients may eliminate vaginal bleeding

A prospective, multi-center study demonstrated that in IVF (in vitro fertilization) cycles supplemented with once-daily dosing of Crinone® vaginal progesterone gel and Estrace® oral estrogen, vaginal bleeding is rare in patients who become pregnant. Bleeding does occur in approximately one-quarter of patients who do not become pregnant. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.

23 Oct 2009

Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic

Theravance, Inc. announced today that it has earned a milestone payment of $20 million for the U.S. Food and Drug Administration (FDA) approval of VIBATIV (telavancin) and supplying its collaboration partner, Astellas Pharma US, Inc. (Astellas), with the launch inventory for the first commercial sale in the United States.

23 Oct 2009

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.

23 Oct 2009

Important guidelines from IDF for diabetes care

The Guidelines are the work of the IDF Task Force on Clinical Guidelines, which is focused on meeting the critical global need to provide up-to-date evidence-based information and training for healthcare professionals.

23 Oct 2009

First clinical trial to test a weight maintenance program for obese pregnant women

More than half of women in the United States are overweight or obese when they become pregnant, and most go on to gain more than the recommended amount during pregnancy. The excess weight can lead to a myriad of complications, including preeclampsia, diabetes, bigger babies, C-sections, birth injuries, and weight retention after pregnancy.

22 Oct 2009

Advisory Committee on Immunization Practices supports the permissive use of GARDASIL

Merck & Co., Inc. announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) supports the permissive use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for boys and young men ages 9 to 26, which means that GARDASIL may be given to males ages 9 to 26 to reduce the likelihood of acquiring genital warts at the discretion of the patient's health care provider.

22 Oct 2009

Obese women retain half of post pregnancy weight

Obese women who gain more than the recommended amount during pregnancy are much more likely to retain a portion of that weight one year after they give birth, according to a Kaiser Permanente study published in the November issue of Obstetrics & Gynecology.

22 Oct 2009

Pregnant women who are lesbians are not receiving the same care as other mothers-to-be: Study

Midwives often struggle to meet the needs of pregnant women who are lesbians, with patients reporting that the focus is often on their sexuality rather than the fact that they are expecting a baby, according to research in the November issue of the Journal of Advanced Nursing.

22 Oct 2009

Researchers develop a non-invasive test to help assess embryo viability for IVF

Embryos that are most likely to result in a pregnancy are crucial to the success of in vitro fertilization (IVF) but are difficult to identify. Researchers at Yale School of Medicine, led by Emre Seli, M.D., are developing a fast, non-invasive test to help assess embryo viability for IVF.

22 Oct 2009

Exposure to stress hormones and chemicals while in the womb can affect male fertility

Exposure to a combination of excess stress hormones and chemicals while in the womb could affect a man's fertility in later life, a study suggests.

22 Oct 2009

Health reform bills maintain some type of insurance 'age rating'

Insurance company "age rating" is likely to continue under proposed health care legislation.

22 Oct 2009

Maternal smoking may increase the level of distress of newborns, says study

A new research study being published in the October 15th issue of Biological Psychiatry suggests that maternal smoking may increase the level of distress of newborns.

21 Oct 2009

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.

21 Oct 2009

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Ferring Pharmaceuticals presented an interim study analysis indicating that MENOPUR® (menotropins for injection, USP) is effective in in vitro fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) antagonist. The results were presented in a poster at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21, 2009.

21 Oct 2009

STR genotyping and p57 immunohistochemistry used to distinguish hydatidiform moles

Researchers from The Johns Hopkins Medical Institutions have used short tandem repeat (STR) genotyping and p57 immunohistochemistry to distinguish hydatidiform moles.

21 Oct 2009

No significant differences in pregnancy outcomes with different progesterone formulations

A retrospective analysis, conducted at a large infertility clinic between January 2003 and December 2008, demonstrated that there were no significant differences in pregnancy outcomes with three different progesterone formulations for women aged 35 to 40 undergoing in vitro fertilization-embryo transfer (IVF-ET) procedures. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.

21 Oct 2009

Study finds lung scintigraphy more reliable than CTA for pulmonary embolism diagnosis in pregnant patients

A medical imaging procedure known as lung scintigraphy may be more reliable than pulmonary CT angiography (CTA) for identifying or excluding pulmonary embolism (PE) in pregnant patients, according to a study published in the November issue of the American Journal of Roentgenology.

21 Oct 2009

Women without HOXA13 gene mutation need not be subjected to X-rays

Hugh S. Taylor, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, and colleagues have found that women without mutations of the HOXA13 gene do not need to be subjected to x-rays and other tests for a rare condition called hand-foot genital syndrome. The research is presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.

20 Oct 2009

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

20 Oct 2009

Pregnancy News and Research

Latest Pregnancy News and Research

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Combination treatement for IVF patients may eliminate vaginal bleeding

Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

Important guidelines from IDF for diabetes care

First clinical trial to test a weight maintenance program for obese pregnant women

Advisory Committee on Immunization Practices supports the permissive use of GARDASIL

Obese women retain half of post pregnancy weight

Pregnant women who are lesbians are not receiving the same care as other mothers-to-be: Study

Researchers develop a non-invasive test to help assess embryo viability for IVF

Exposure to stress hormones and chemicals while in the womb can affect male fertility

Health reform bills maintain some type of insurance 'age rating'

Maternal smoking may increase the level of distress of newborns, says study

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

STR genotyping and p57 immunohistochemistry used to distinguish hydatidiform moles

No significant differences in pregnancy outcomes with different progesterone formulations

Study finds lung scintigraphy more reliable than CTA for pulmonary embolism diagnosis in pregnant patients

Women without HOXA13 gene mutation need not be subjected to X-rays

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Pregnancy News and Research

Latest Pregnancy News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in